,

Mia C Weiss1,2, Vanessa Eulo3, Brian A Van Tine1,2,4

  • 1Washington University in St. Louis, School of Medicine, Department of Medicine, Division of Medical Oncology, St. Louis, Missouri.

概括

分离性脂瘤瘤 (DDLPS) 显示出 CDK4 抑制剂以染色体 12q.q 为向的 CDK4 抑制剂具有前景. 了解细胞转化是预测患者对这些疗法的反应的关键.